Atlas Trials

Compassionate Use of Ubamatamab

Clinical trial NCT07502716 · AVAILABLE

Trial details

NCT number
NCT07502716
Sponsor
Regeneron Pharmaceuticals
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Renal Medullary Carcinoma (RMC)Epithelioid Sarcoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.